Cantor Fitzgerald resumed coverage on Aspira Women's Health with a new price target

1/12/22 7:53:25 AM ET

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Health Care

Cantor Fitzgerald resumed coverage of Aspira Women's Health with a rating of Overweight and set a new price target of $4.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$AWH

Date	Price Target	Rating	Analyst
1/12/2022	$4.00	Overweight	Cantor Fitzgerald